# Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission

> **NCT00667927** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 17 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Busulfan
- **DRUG:** Cyclophosphamide
- **DRUG:** Mesna

## Key facts

- **NCT ID:** NCT00667927
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-03
- **Primary completion:** 1995-01
- **Final completion:** 2008-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2008-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00667927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00667927, "Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00667927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*